DK0789761T3 - Human SCF, en splejsningsvariant deraf, dens farmaceutiske anvendelse - Google Patents

Human SCF, en splejsningsvariant deraf, dens farmaceutiske anvendelse

Info

Publication number
DK0789761T3
DK0789761T3 DK95935513T DK95935513T DK0789761T3 DK 0789761 T3 DK0789761 T3 DK 0789761T3 DK 95935513 T DK95935513 T DK 95935513T DK 95935513 T DK95935513 T DK 95935513T DK 0789761 T3 DK0789761 T3 DK 0789761T3
Authority
DK
Denmark
Prior art keywords
leu
splice variant
pharmaceutical use
terminal sequence
human scf
Prior art date
Application number
DK95935513T
Other languages
English (en)
Inventor
Kimberley Anne Nat Hear Dellow
Stephen Kevin Smith
Andrew Mark Sharkey
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9422293A external-priority patent/GB9422293D0/en
Priority claimed from GBGB9508618.7A external-priority patent/GB9508618D0/en
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0789761T3 publication Critical patent/DK0789761T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK95935513T 1994-11-04 1995-10-31 Human SCF, en splejsningsvariant deraf, dens farmaceutiske anvendelse DK0789761T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422293A GB9422293D0 (en) 1994-11-04 1994-11-04 Therapeutic protein
GBGB9508618.7A GB9508618D0 (en) 1995-04-28 1995-04-28 Therapeutic protein

Publications (1)

Publication Number Publication Date
DK0789761T3 true DK0789761T3 (da) 2005-11-28

Family

ID=26305929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95935513T DK0789761T3 (da) 1994-11-04 1995-10-31 Human SCF, en splejsningsvariant deraf, dens farmaceutiske anvendelse

Country Status (13)

Country Link
US (1) US6177556B1 (da)
EP (1) EP0789761B1 (da)
JP (1) JP3961565B2 (da)
AT (1) ATE299934T1 (da)
AU (1) AU708755B2 (da)
CA (1) CA2203372C (da)
DE (1) DE69534324T2 (da)
DK (1) DK0789761T3 (da)
ES (1) ES2242192T3 (da)
IL (1) IL115825A (da)
PT (1) PT789761E (da)
SI (1) SI0789761T1 (da)
WO (1) WO1996014410A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US5969105A (en) * 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
AU8827998A (en) * 1997-08-14 1999-03-08 Biotransplant Incorporated Porcine totipotent cells and method for long-term culture
US6703209B1 (en) 1998-08-13 2004-03-09 Biotransplant, Inc. Porcine totipotent cells and method for long-term culture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0676470A1 (en) 1989-10-16 1995-10-11 Amgen Inc. Stem cell factor
US5885962A (en) * 1996-04-05 1999-03-23 Amgen Inc. Stem cell factor analog compositions and method

Also Published As

Publication number Publication date
CA2203372C (en) 2008-03-11
ATE299934T1 (de) 2005-08-15
PT789761E (pt) 2005-09-30
EP0789761B1 (en) 2005-07-20
AU708755B2 (en) 1999-08-12
IL115825A (en) 2006-07-05
MX9703256A (es) 1998-07-31
ES2242192T3 (es) 2005-11-01
DE69534324T2 (de) 2006-01-05
SI0789761T1 (en) 2005-10-31
JP3961565B2 (ja) 2007-08-22
JPH10508480A (ja) 1998-08-25
CA2203372A1 (en) 1996-05-17
DE69534324D1 (de) 2005-08-25
AU3750895A (en) 1996-05-31
WO1996014410A1 (en) 1996-05-17
EP0789761A1 (en) 1997-08-20
IL115825A0 (en) 1996-01-19
US6177556B1 (en) 2001-01-23

Similar Documents

Publication Publication Date Title
NL300013I2 (nl) Nieuwe proteinen me TNF-remmende werking en hun bereiding.
ES2144179T3 (es) Inhibidores de adhesion ciclicos.
HUP0103114A2 (hu) Apolipoprotein A-1 agonisták és alkalmazásuk diszlipidémiás rendellenességek kezelésében
AR002024A1 (es) Proteinas utiles para el tratamiento de la obesidad, composiciones farmaceuticas que incluyen dichas proteinas para tratamientos anti-obesidady procedimiento para prepararlas.
BR9406720A (pt) Utilização de um adenovírus recombinante de origem animal adenovírus recombinante de origem animal e composição farmacêutica compreendendo um ou vários adenovírus
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
NO942553D0 (no) Ny humanproteaseinhibitor av Kunitz-type og varianter derav
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
YU29596A (sh) Genski proizvodi koji regulišu gojaznost
EP0810285A3 (en) Mutants of human Interleukin-3
GR880100775A (el) Παράγοντας ενεργοποιήσεως ουδετεροφίλων.
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
DK0789761T3 (da) Human SCF, en splejsningsvariant deraf, dens farmaceutiske anvendelse
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
HUP9702500A2 (hu) Elhízás elleni proteinek
WO1997012036A3 (en) Bone stimulating factor
BR0007816A (pt) Fator de estimulação óssea
ES2171157T3 (es) Gen recombinante codificante para una proteina con actividad endoquitinasa.
WO2001051512A3 (en) Human and parasite orphan receptor proteins
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
DE59207735D1 (de) Neues thrombininhibitorisches protein aus zecken
ECSP972344A (es) Proteinas antiobesidad
TH34900A (th) โปรตีนยับยั้งความอ้วน
ES2183376T3 (es) Uso de lbp para el tratamiento de la septicemia.
MX9709618A (es) Factores estimulantes de huesos.